Coverage summary
Aardvark Labs Capital Research has covered Oracle Corporation (ORCL) since December 10, 2024. The company is in the Technology sector. This page lists 8 reports: 8 earnings recaps.
The latest is the Q1 FY27 Earnings Recap, published September 22, 2026. The current rating is Outperform, unchanged since the Q3 FY25 Earnings Recap of March 11, 2025. The rating has changed once since coverage began.
Translations: 8 in Chinese.
The Excel model for ORCL holds 16 quarters and 5 fiscal years of history and 8 quarters and 5 fiscal years of projections. It was last updated June 12, 2026.
Rating history
All ORCL reports
Recap: Q1 FY27
OCI +121%, the Guide Goes Up, and the Equity Program Is Done. But Strip Out $11.4B of Prepayments and the Cash Burn Is Three Times the Headline
Recap: Q4 FY26
The Backlog Says $638B, the Cash Flow Says −$24B: Record RPO and a $90B FY27 Guide Collide With a $55.7B Capex Bill and a $40B Raise — Maintaining Outperform
Recap: Q3 FY26
A Clean, Gain-Free Beat Ends the Slide: OCI Accelerates to +84%, the $30B Funding Plan Lands, and ORCL Rallies 9%. Maintaining Outperform
Recap: Q2 FY26
RPO Vaults to $523B and OCI Reaccelerates to +68%, but a Capex Shock to ~$50B and −$10B Free Cash Flow Sink the Stock 11%: Maintaining Outperform
Recap: Q1 FY26
RPO Inflects to $455B, OCI Guide Laid Out at $144B by FY30 — the OpenAI / Stargate Reset: Maintaining Outperform, FV $310–360
Recap: Q4 FY25
Maintaining Outperform: Headline Beat, RPO $138B, and an FY26 Raise to >$67B Confirm the Bookings-to-Revenue Cascade Is Delivering
Recap: Q3 FY25
Upgrading to Outperform: $48B In-Quarter Bookings, RPO $130B (+63% cc), and FY27 Acceleration to ~20% Tick All Four Boxes From Our Initiation Note
Recap: Q2 FY25
Initiating Coverage at Hold: RPO Step-Function to $97.3B (+50%) and OCI +52% Validate the Hyperscale Pivot, But Capex Absorption and AI Customer Concentration Keep Us Patient